Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5176 AL 5190

Plasma biomarkers for Alzheimer's disease: much needed but tough to find

Bazenet C, Lovestone S.

Biomark Med. 2012 Aug;6(4):441-54. doi: 10.2217/bmm.12.48.

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease

Fagan AM, Perrin RJ.

Biomark Med. 2012 Aug;6(4):455-76. doi: 10.2217/bmm.12.42.

Mild cognitive impairment: a subset of minor neurocognitive disorder?

Geda YE, Nedelska Z.

Am J Geriatr Psychiatry. 2012 Oct;20(10):821-6. doi: 10.1097/JGP.0b013e31826abc00.

Longitudinal stability evaluation of biomarkers and their correlation in cerebrospinal fluid and plasma from patients with Alzheimer's disease

Höglund K, Bogstedt A, Fabre S, Aziz A, Annas P, Basun H, Minthon L, Lannfelt L, Blennow K, Andreasen N.

J Alzheimers Dis. 2012;32(4):939-47. doi: 10.3233/JAD-2012-120976.

[Markers of prodromal Alzheimer's disease]

de Souza LC, Sarazin M, Uspenskaya O, Habert MO, Lamari F, Lehéricy S, Dubois B.

Rev Neurol (Paris). 2012 Nov;168(11):815-24. doi: 10.1016/j.neurol.2012.07.005. Epub 2012 Sep 1.

Fluid biomarkers in Alzheimer disease

Blennow K, Zetterberg H, Fagan AM.

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006221. doi: 10.1101/cshperspect.a006221.

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias

Genius J, Klafki H, Benninghoff J, Esselmann H, Wiltfang J.

Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S71-7. doi: 10.1007/s00406-012-0362-3. Epub 2012 Sep 18.

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?

Olah Z, Pakaski M, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Sep;14(3):165-76.

Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease

Wu G, Sankaranarayanan S, Wong J, Tugusheva K, Michener MS, Shi X, Cook JJ, Simon AJ, Savage MJ.

J Neurosci Res. 2012 Dec;90(12):2247-58. doi: 10.1002/jnr.23122. Epub 2012 Sep 18.

Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention

Vanitallie TB.

Metabolism. 2013 Jan;62 Suppl 1:S30-3. doi: 10.1016/j.metabol.2012.08.024. Epub 2012 Sep 26.

Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease

Xu XH, Huang Y, Wang G, Chen SD.

Neurosci Bull. 2012 Oct;28(5):641-8. doi: 10.1007/s12264-012-1272-0. Epub 2012 Oct 3.

Translational proteomics in Alzheimer's disease and related disorders

Ghidoni R, Paterlini A, Benussi L.

Clin Biochem. 2013 Apr;46(6):480-6. doi: 10.1016/j.clinbiochem.2012.10.012. Epub 2012 Oct 23.

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals

Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P.

BMC Med. 2012 Oct 25;10:127. doi: 10.1186/1741-7015-10-127.

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia

Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctôt KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R.

Alzheimers Dement. 2013 May;9(3):e96-e105. doi: 10.1016/j.jalz.2012.01.014. Epub 2012 Oct 27.

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician

Budson AE, Solomon PR.

Neurologist. 2012 Nov;18(6):356-63. doi: 10.1097/NRL.0b013e31826a998d.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias